PAP Adherence After Diet/Lifestyle Intervention in OSA Patients

NCT ID: NCT05881824

Last Updated: 2023-05-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-01

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to explore the role of diet/lifestyle intervention on Positive airway pressure (PAP) treatment adherence in patients with obstructive sleep apnea (OSA).Specifically, we evaluated the effects of a combination of PAP and weight-loss Mediterranean diet intervention on improving PAP adherence, Body mass index (ΒΜΙ), daytime symptoms, mainly sleepiness and arterial blood pressure measurements over the effect of standard care alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We designed a parallel, randomized, controlled, clinical trial. Eligible participants are adult, overweight and obese men and women, diagnosed with moderate-to-severe OSA \[apnea-hypopnea index (AHI)≥15 events/h\] through an attended overnight polysomnography. Participants, after written informed consent, were blindly randomized to a standard care group (SCG, n=37) and a Mediterranean diet group (MDG, n=37). Study groups were prescribed PAP. The SCG received oral healthy lifestyle advice and counseling on physical activity and sleep habits, while the MDG was additionally subjected to a 6-month behavioral intervention aiming at weight loss and increasing adherence to the Mediterranean diet. PAP adherence (hours of device use), BMI, daytime sleepiness, evaluated by Epworth Sleepiness Scale (ESS) and arterial blood pressure measurements were evaluated pre- and post-intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard care group (SCG)

The SCG received oral healthy lifestyle advice and counseling on physical activity and sleep habits

Group Type NO_INTERVENTION

No interventions assigned to this group

Mediterranean diet group (MDG)

The MDG was additionally subjected to a 6-month behavioral intervention aiming at weight loss and increasing adherence to the Mediterranean diet.

Group Type ACTIVE_COMPARATOR

MDG intervention

Intervention Type BEHAVIORAL

6-month behavioral intervention aiming at weight loss and increasing adherence to the Mediterranean diet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MDG intervention

6-month behavioral intervention aiming at weight loss and increasing adherence to the Mediterranean diet

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged \>18 years with newly diagnosed moderate to severe OSA \[apnea-hypopnea index (AHI)≥15 events/h\] through an attended overnight polysomnographyaccording to standard criteria
* overweight and obese \[BMI\>25 kg/m2\]
* eligible for PAP treatment with adherence data available in the 6-months after initiation of treatment and
* with an above-elementary school education.

Exclusion Criteria

* refusal to participate
* patients on PAP treatment
* current participation in a weight loss program
* central sleep apnea syndromes
* obesity hypoventilation syndrome
* restrictive ventilator syndromes
* severe congestive heart failure
* a history of life-threatening arrhythmias
* severe cardiomyopathy
* long-term oxygen therapy
* chronic kidney disease
* family or personal history of mental illness
* drug or alcohol abuse
* severe cognitive impairment
* concurrent oncological diseases
* pregnancy or lactatio
* recent hospitalization for acute or chronic respiratory disease
* history of narcolepsy or restless leg syndrome
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Crete

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Izolde Bouloukaki

Clinical Researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sophia Schiza, MD

Role: STUDY_CHAIR

University of Crete

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Crete

Heraklion, Crete, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OSADIET1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Time Restricted Eating in Sleep Apnea
NCT06047496 RECRUITING EARLY_PHASE1